Jilin Aodong Pharmaceutical Group Co.,Ltd.’s Net Profit Rose 792% in First Quarter of 2023
Listen to the full version

Jilin Aodong Pharmaceutical Group Co.,Ltd. (吉林敖东药业集团股份有限公司) (000623.SZ) reported a net profit of 490.5 million yuan in the first quarter of 2023, up 792% year-on-year.
Meanwhile, the company posted 787.7 million yuan in revenue, up 23.6% year-on-year.
At the end of the reporting period, it had 31.5 billion yuan in total assets and 4.7 billion yuan in total liabilities, with a liability-to-asset ratio of 14.8%.
Unlock exclusive discounts with a Caixin group subscription — ideal for teams and organizations.
Subscribe to both Caixin Global and The Wall Street Journal — for the price of one.
- PODCAST
- MOST POPULAR